SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHO) — FDA Approval ANDA216885 (PRINSTON P
SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHO) — FDA Approval ANDA216885 (PRINSTON P is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE; Active ingredients: METFORMIN HYDROCHLORIDE, SITAGL
| Brand name | SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE |
|---|---|
| Active ingredients | METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE |
| Application number | ANDA216885 |
| Sponsor | PRINSTON PHARMACEUTICAL INC |
| Dosage form | TABLET |
| Route | FILM COATED |
| Marketing status | None (Tentative Approval) |
| Products in application | 3 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →